Search results
Mar 19, 2024 · Tel Aviv, Israel / Vancouver, Canada, March 19, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY) (“Clearmind” or the "company"), a biotech company focused on...
Jan 10, 2024 · About Clearmind Medicine Inc. Clearmind is a psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread...
Nov 9, 2023 · Clearmind Medicine to Pioneer Psychedelic Clinical Trials for Alcohol Use Disorder with Ivy League Universities. November 09, 2023 09:20 ET | Source: Clearmind Medicine Inc. Follow. Company...
Clearmind Medicine (Nasdaq: CMND, FSE: CWY0) develops novel psychedelic medicines to solve widespread, yet under-served, health problems. With a strong medical management team and...
Feb 20, 2024 · Vancouver, Canada, Feb. 20, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq, CSE: CMND), (FSE: CWY) (“Clearmind” or the "company"), a biotech company focused on discovery and...
May 7, 2024 · Clearmind is a clinical-stage psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved...
Clearmind Medicine Files U.S. Patent Application for Psychedelic-Based Treatment for Eating Disorders. Read More. 9. April. 2024. Clearmind Medicine CEO Issues Letter to Shareholders. Read More. 27. March. 2024. Clearmind Medicine Announces International Patent Application for Preventing and Treating Depression. Read More. 13. March. 2024.
